The upcoming CC should be very entertaining in terms of Nasrat and Carter bantering about undershooting estimates and enjoy the rewards of their years of hard work.
How many times did Nasrat have to defend his actions and just say that financially it didn't make any sense to do anything about share price except work harder at developing and marketing profitable drugs. So many people here screamed about them putting out PRs, doing a reverse split, going to Nasdaq, buying the other half of the Adderall, etc. BTW, buying the other half of the Adderall license would have only giving us an extra $1million per quarter in licensing fees. Which is chump change when instead that $1 million was put into research and BE studies for new BILLION dollar products. What matters to these new investors is our new billion dollar products not an extra Adderall per quarter of around 1 million dollars.
So glad Nasrat is our CEO and no one on this board!!
Market Data 
Markets 
AI
